Concepedia

Volker Knappertz

VK

39

Publications

2.5K

Citations

26

H-Index

1994

Active since

Affiliations

Bayer (United States)(Current)

Heinrich Heine University Düsseldorf

Teva Pharmaceuticals (United States)

University of California, San Francisco

Bayer (Germany)

Volker Knappertz is an author at Bayer (United States) specializing in medicine, neurology, and multiple sclerosis.

Top concepts

MedicineNeurologyMultiple SclerosisHealthNeuroscienceNeuroimmunologyImmunologyPublic HealthNeuropathologyOutcomes Research

Publications per year

1994–2022

39

Publications

39

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

Paul O’Connor, Massimo Filippi, Barry G.W. Arnason et al. · The Lancet Neurology · 2009 · 402 citations · Full text

Relapsing-remitting Multiple Sclerosis, Neurological Disorder, Multicentre Study +8

Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome

Ian Miller, Ingrid E. Scheffer, Boudewijn Gunning et al. · JAMA Neurology · 2020 · 248 citations · Full text

Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex

Elizabeth A. Thiele, E. Martina Bebin, Hari Bhathal et al. · JAMA Neurology · 2020 · 246 citations · Full text

Douglas S. Goodin, Anthony T. Reder, George C. Ebers et al. · Neurology · 2012 · 242 citations · Full text

Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor

Joel Kaye, Victor Piryatinsky, Tal Birnberg et al. · Proceedings of the National Academy of Sciences · 2016 · 133 citations · Full text

Rows per page

1–5 of 39